LINC01232 serves as a novel biomarker and promotes tumour progression by sponging miR-204-5p and upregulating RAB22A in clear cell renal cell carcinoma

References

• Escudier B, Porta C, Schmidinger M, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019;30(5):706–720.
   PubMed Web of Science ®Google Scholar
• Wolf MM, Kimryn Rathmell W, Beckermann KE. Modeling clear cell renal cell carcinoma and therapeutic implications. Oncogene. 2020;39(17):3413–3426.
   PubMed Web of Science ®Google Scholar
• Xue J, Zhu S, Qi F, et al. RUNX1/miR-582-5p pathway regulates the tumor progression in clear cell renal cell carcinoma by targeting COL5A1. Front Oncol. 2021;11:610992.
   PubMed Web of Science ®Google Scholar
• Petitprez F, Ayadi M, de Reynies A, et al. Review of prognostic expression markers for clear cell renal cell carcinoma. Front Oncol. 2021;11:643065.
   PubMed Web of Science ®Google Scholar
• Li Y, Huo FF, Wen YY, et al. Screening and identification of an immune-associated lncRNA prognostic signature in ovarian carcinoma: evidence from bioinformatic analysis. Biomed Res Int. 2021;2021:6680036.
   PubMed Web of Science ®Google Scholar
• Wang B, Tang D, Liu Z, et al. LINC00958 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma cells. PLoS One. 2021;16(5):e0251797.
   PubMed Web of Science ®Google Scholar
• Song K, Yu P, Zhang C, et al. The LncRNA FGD5-AS1/miR-497-5p axis regulates septin 2 (SEPT2) to accelerate cancer progression and increase cisplatin-resistance in laryngeal squamous cell carcinoma. Mol Carcinog. 2021; 60:469-480
   Web of Science ®Google Scholar
• Xie FW, Liu JC. LncRNA SNHG12 regulates the miR-101-3p/CUL4B axis to mediate the proliferation, migration and invasion of non-small cell lung cancer. Kaohsiung J Med Sci. 2021; 37:664-674.
   Web of Science ®Google Scholar
• Li Q, Lei C, Lu C, et al. LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2. Cell Death Dis. 2019;10(10):698.
   PubMed Web of Science ®Google Scholar
• Du W, Lei C, Wang Y, et al. LINC01232 sponges multiple miRNAs and its clinical significance in pancreatic adenocarcinoma diagnosis and prognosis. Technol Cancer Res Treat. 2021;20:1533033820988525.
   Web of Science ®Google Scholar
• Zhao M, Cui H, Zhao B, et al. Long intergenic non‑coding RNA LINC01232 contributes to esophageal squamous cell carcinoma progression by sequestering microRNA‑654‑3p and consequently promoting hepatoma‑derived growth factor expression. Int J Mol Med. 2020;46(6):2007–2018.
   PubMed Web of Science ®Google Scholar
• Chen M, Xu X, Ma H. Identification of oncogenic long noncoding RNAs CASC9 and LINC00152 in oral carcinoma through genome-wide comprehensive analysis. Anticancer Drugs. 2019;30(4):356–362.
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92–D97.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• He L, Wang J, Zhou L, et al. LncRNA PCAT18 promotes non-small cell lung cancer progression by sponging miR-4319. Cancer Manag Res. 2021;13:3761–3774.
   PubMed Web of Science ®Google Scholar
• Ma X, Li Y, Song Y, et al. Long noncoding RNA CCDC26 promotes thyroid cancer malignant progression via miR-422a/EZH2/Sirt6 axis. Onco Targets Ther. 2021;14:3083–3094.
   PubMed Web of Science ®Google Scholar
• Cheng T, Shuang W, Ye D, et al. SNHG16 promotes cell proliferation and inhibits cell apoptosis via regulation of the miR-1303-p/STARD9 axis in clear cell renal cell carcinoma. Cell Signal. 2021;84:110013.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gong P, Yao D, et al. LncRNA HCG18 promotes clear cell renal cell carcinoma progression by targeting miR-152-3p to upregulate RAB14. Cancer Manag Res. 2021;13:2287–2294.
   PubMed Web of Science ®Google Scholar
• Meng LD, Shi GD, Ge WL, et al. Linc01232 promotes the metastasis of pancreatic cancer by suppressing the ubiquitin-mediated degradation of HNRNPA2B1 and activating the A-Raf-induced MAPK/ERK signaling pathway. Cancer Lett. 2020;494:107–120.
   PubMed Web of Science ®Google Scholar
• Geers R, Ingram DL, Dauncey MJ. Time course of the change in nuclear 3,5,3'-triiodothyronine receptors of skeletal muscle in relation to energy intake. Q J Exp Physiol. 1988;73(3):447–449.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sun Y, Ding L, et al. Long non-coding RNA LINC00467 correlates to poor prognosis and aggressiveness of breast cancer. Front Oncol. 2021;11:643394.
   PubMed Web of Science ®Google Scholar
• Jia X, Wei L, Zhang Z. NEAT1 overexpression indicates a poor prognosis and induces chemotherapy resistance via the miR-491-5p/SOX3 signaling pathway in ovarian cancer. Front Genet. 2021;12:616220.
   PubMed Web of Science ®Google Scholar
• Gao L, Zhao A, Wang X. Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma. Oncol Lett. 2020;19(6):3993–4001.
   PubMed Web of Science ®Google Scholar
• Ding C, Han F, Xiang H, et al. LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma. J Cell Biochem. 2018;119(12):10406–10414.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Li W, Yan Y, et al. LINC01094 triggers radio-resistance in clear cell renal cell carcinoma via miR-577/CHEK2/FOXM1 axis. Cancer Cell Int. 2020;20:274.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zheng Y, Shao X, et al. Long non-coding RNA TPT1-AS1 sensitizes breast cancer cell to paclitaxel and inhibits cell proliferation by miR-3156-5p/caspase 2 axis. Hum Cell. 2021; 34:1244-1254.
   Web of Science ®Google Scholar
• Wu J, Liu T, Sun L, et al. Long noncoding RNA SNHG4 promotes renal cell carcinoma tumorigenesis and invasion by acting as ceRNA to sponge miR-204-5p and upregulate RUNX2. Cancer Cell Int. 2020;20:514.
   PubMed Web of Science ®Google Scholar
• Shu X, Hildebrandt MA, Gu J, et al. MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity. Br J Cancer. 2017;116(1):77–84.
   PubMed Web of Science ®Google Scholar
• Gowrishankar B, Ibragimova I, Zhou Y, et al. MicroRNA expression signatures of stage, grade, and progression in clear cell RCC. Cancer Biol Ther. 2014;15(3):329–341.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yin Y, Hu Y, et al. MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A. Med Oncol. 2015;32(1):331.
   PubMed Web of Science ®Google Scholar
• Xia Z, Liu F, Zhang J, et al. Decreased expression of MiRNA-204-5p contributes to glioma progression and promotes glioma cell growth, migration and invasion. PLoS One. 2015;10(7):e0132399.
   PubMed Web of Science ®Google Scholar
• Xiong F, Liu K, Zhang F, et al. MiR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expression. Oncol Rep. 2016;35(5):3000–3008.
   PubMed Web of Science ®Google Scholar
• Mayorga LS, Cebrian I. Rab22a: a novel regulator of immune functions. Mol Immunol. 2019;113:87–92.
   PubMed Web of Science ®Google Scholar
• Flaifel A, Xie W, Braun DA, et al. PD-L1 expression and clinical outcomes to cabozantinib, everolimus, and sunitinib in patients with metastatic renal cell carcinoma: analysis of the randomized clinical trials METEOR and CABOSUN. Clin Cancer Res. 2019;25(20):6080–6088.
   PubMed Web of Science ®Google Scholar
• Marquardt A, Solimando AG, Kerscher A, et al. Subgroup-independent mapping of renal cell carcinoma-machine learning reveals prognostic mitochondrial gene signature beyond histopathologic boundaries. Front Oncol. 2021;11:621278.
   PubMed Web of Science ®Google Scholar
• Zhang M, Cao M, Kong L, et al. MiR-204-5p promotes lipid synthesis in mammary epithelial cells by targeting SIRT1. Biochem Biophys Res Commun. 2020;533(4):1490–1496.
   PubMed Web of Science ®Google Scholar